All treatments
Treatment
RINVOQ 15 mg prolonged-release tablets clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic use (Phase IV)
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)
This study looks at how a drug called Rinvoq (upadacitinib) affects people with a type of arthritis called axial spondyloarthritis who also experience recurrent eye inflammation (uveitis). It aims to see if Rinvoq can reduce flare-ups of this eye condition.
For: Acute Anterior Uveitis · Axial SpondyloarthritisSpain · Poland · Netherlands - Ongoing, recruitingTherapeutic use (Phase IV)
U3P study - Upadacitinib in Psoriatic Arthritis Pain Processing
The U3P study is looking at how a medicine called RINVOQ (upadacitinib) helps people with psoriatic arthritis pain. Researchers will check brain scans to see how the pain changes over time, aiming to understand how this treatment works in the body.
For: Psoriatic arthritisGermany